$RENX Balance Sheet | Understand Stock

$RENX

$1.03 -$0.19 (15.57%) Close

$RENX Overview Financial Statements SEC Filings Executives News Red Flags Capital Raising Ownership Insider Transactions Congressional Trades

Financial Statements

Income Statement Balance Sheet Cashflow Statement

Consolidated Balance Sheets

In millions of USD, except per-share amounts

	Q2 FY2026 As of Jun 30, 2026	Q1 FY2026 As of Mar 31, 2026	Q4 FY2025 As of Dec 31, 2025	Q3 FY2025 As of Sep 30, 2025	Q2 FY2025 As of Jun 30, 2025	Q1 FY2025 As of Mar 31, 2025	Q4 FY2024 As of Dec 31, 2024	Q3 FY2024 As of Sep 30, 2024	Q2 FY2024 As of Jun 30, 2024	Q1 FY2024 As of Mar 31, 2024	Q4 FY2023 As of Dec 31, 2023	Q3 FY2023 As of Sep 30, 2023
Current Assets
Cash
Prepaid assets and other current assets
Inventory
Current assets of discontinued operations
Accounts receivable, net
Current Assets
Assets held for sale
Land
Land
Total land
Property and equipment, net
Project development costs and other non-current assets
Due from affiliates
Equity-based investments
Intangible assets, net
Right of use assets
Goodwill
Long-term assets of discontinued operations
Total Assets
Current Liabilities
Accounts payable and accrued expenses
Due to affiliates
Affiliates
Total due to affiliates
Short-term notes payable, net
Deferred gain on sale
Notes payable - related party, current
Related Party
Total notes payable - related party, current
Operating lease liabilities, current
Finance lease liabilities, current
Derivative liability
Current liabilities of discontinued operations
Total Current Liabilities
Contingent consideration liability
Long-term debt, net
Operating lease liabilities
Finance lease liabilities
Total Liabilities
Commitments and contingencies
Stockholder’s Equity:
Preferred stock, value
Series A Preferred
Series B Preferred
Series C Preferred
Total preferred stock, value
Common stock, $0.001 par value, 500,000,000 shares authorized, 2,621,925 issued and 2,613,742 outstanding as of June 30, 2026 and, 946,742 issued and 938,559 outstanding as of December 31, 2025
Additional paid-in capital
Accumulated deficit
Total stockholder’s equity
Non-controlling interest
Total Stockholder’s Equity
Total Liabilities and Stockholder’s Equity

Comments